|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4174 | |
| A61K 9/08 | |||
| A61P 29/00 |
| (11) | Number of the document | 2787970 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12857098.3 |
| Date of filing the European patent application | 2012-12-11 | |
| (97) | Date of publication of the European application | 2014-10-15 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/068988 |
| Date | 2012-12-11 |
| (87) | Number | WO 2013/090278 |
| Date | 2013-06-20 |
| (30) | Number | Date | Country code |
| 201161569255 P | 2011-12-11 | US |
| (72) |
HENWOOD, Geraldine A., US
MACK, Randall J., US
KOLENG, JR., John Joseph, US
SHARR, Christopher T., US
FREYER, Charles Alexander, US
|
| (73) |
Recro Pharma, Inc.,
490 Lapp Road, Malvern, PA 19355,
US
|
| (54) | INTRANASAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF |
| INTRANASAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF |